Recombinantly expressed rabbit zona pellucida polypeptides
Patent 4996297 Issued on February 26, 1991. Estimated Expiration Date: 
February 26, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 26, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesAnti-fertility vaccine comprising solubilized zona pellucida and anti-serum Antigenic modification of polypeptides Method for contraception by immunization against the zona pellucida Patent #: 4795634 InventorAssigneeApplicationNo. 106087 filed on 10/07/1987US Classes:424/185.1, Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same424/559, Genitalia (e.g., ovary, uterus, prostate, testis, etc.)424/811, INVOLVING SEX SELECTION OR CONTRACEPTION514/2, Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI514/8, Glycoprotein (carbohydrate containing)514/21, Produced by or extracted from animal tissue530/350, PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES530/380, Blood proteins or globulins, e.g., proteoglycans, platelet factor 4, thyroglobulin, thyroxine, etc.530/387.9, Binds specifically-identified amino acid sequence530/388.2, Binds microorganism or normal or mutant component or product thereof (e.g., animal cell, cell-surface antigen, secretory product, etc.)530/389.1, Polyclonal antibody or immunogloblin of identified binding specificity530/395, Glycoprotein, e.g., mucins proteoglycans, etc.530/806, ANTIGENIC PEPTIDES OR PROTEINS530/808, MATERIALS AND PRODUCTS RELATED TO GENETIC ENGINEERING OR HYBRID OR FUSED CELL TECHNOLOGY, E.G., HYBRIDOMA, MONOCLONAL PRODUCTS, ETC.530/850, Reproductive organs or embryos530/853Ovary; eggs; embryosExaminersPrimary: Moskowitz, MargaretAssistant: Kushan, Jeff Attorney, Agent or FirmForeign Patent References
International ClassesC07K 015/14A61K 037/02 AbstractThe invention relates to antigenic preparations useful for inducing the production of antibodies in an individual which will bind to epitopes on zona pellucida. Also disclosed are immunogenic compositions and methods for immunizing an individual to enable the production of antibodies to zona pellucida antigens. Also disclosed are the use of these recombinant molecules and monoclonal antibodies thereto for immunocontraception or sterilization.Other References
Field of SearchGlycoprotein, e.g., mucins proteoglycans, etc.PROTEINS, I.E., MORE THAN 100 AMINO ACID RESIDUES MATERIALS AND PRODUCTS RELATED TO GENETIC ENGINEERING OR HYBRID OR FUSED CELL TECHNOLOGY, E.G., HYBRIDOMA, MONOCLONAL PRODUCTS, ETC. Fused cells, e.g., hybridoma, etc. Placenta; amniotic fluid Reproductive organs or embryos Ovary; eggs; embryos Glycoprotein (carbohydrate containing) Produced by or extracted from animal tissue Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI Genitalia (e.g., ovary, uterus, prostate, testis, etc.) |
| ||||||||||||||
